Physician

Kent A Zocchi, M.D.

According to 2025 Medicare claims, Kent Zocchi, M.D. (NPI: 1629028733) practices ophthalmology in the Hot Springs, AR market, with the plurality of this provider's patient population coming from Garland, AR. This provider's primary affiliated billing organization is RETINA ASSOCIATES, P.A. (NPI: 1447215603; TIN: 71-0706742) and primary practice location at 72205-6243.

Zocchi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,047 traditional Medicare patients, billed 26,145 HCPCS/CPT codes, and received $1,837,710 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 705 prescription claims across 204 beneficiaries totaling $27,124 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 15 records totaling $541. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.2M$2.5M2015 Medicare payment: $1,420,918 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,456,799 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,563,167 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,015,152 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,466,496 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,932,129 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,977,676 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,931,832 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,853,057 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,837,710 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,39413,717$1,420,918
20161,48116,073$1,456,799
20171,46715,632$1,563,167
20181,44216,067$2,015,152
20191,83818,608$2,466,496
20201,44213,340$1,932,129
20211,28614,582$1,977,676
20221,24814,398$1,931,832
20231,08221,969$1,853,057
20241,04726,145$1,837,710

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$43K$86K2015 Drug cost: $18,403 (USD; Tot_Drug_Cst)2016 Drug cost: $17,752 (USD; Tot_Drug_Cst)2017 Drug cost: $17,811 (USD; Tot_Drug_Cst)2018 Drug cost: $35,605 (USD; Tot_Drug_Cst)2019 Drug cost: $34,492 (USD; Tot_Drug_Cst)2020 Drug cost: $86,115 (USD; Tot_Drug_Cst)2021 Drug cost: $31,999 (USD; Tot_Drug_Cst)2022 Drug cost: $34,365 (USD; Tot_Drug_Cst)2023 Drug cost: $33,824 (USD; Tot_Drug_Cst)2024 Drug cost: $27,124 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015117399$18,403
2016114366$17,752
2017129410$17,811
2018156520$35,605
2019178561$34,492
2020177702$86,115
2021187665$31,999
2022154610$34,365
2023211766$33,824
2024204705$27,124

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg2051,246$659
67028Injection of drug into eye5161,595$78
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more7991,583$58
J9035Injection, bevacizumab, 10 mg240754$55
92134Imaging of retina9692,397$26

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate2279,166$11,965
Brimonidine TartrateBrimonidine Tartrate703,870$3,895
Atropine SulfateAtropine Sulfate411,285$1,252
DifluprednateDifluprednate11362$1,151
Dorzolamide HclDorzolamide Hcl543,392$928

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.15$541Alimera Sciences, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Kent A. Zocchi, M.D.?

Tedicare shows public-source Medicare data for Kent A. Zocchi, M.D. (NPI 1629028733), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kent A. Zocchi, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kent A. Zocchi, M.D.?

Kent A. Zocchi, M.D. is linked to RETINA ASSOCIATES, P.A. (billing NPI 1447215603) in the available physician profile data.

Does Kent A. Zocchi, M.D. have Open Payments data?

Kent A. Zocchi, M.D. has 15 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.